Skip to main content
Premium Trial:

Request an Annual Quote

ERS Genomics Licenses CRISPR IP to GenOway

NEW YORK — ERS Genomics said on Monday that it has nonexclusively licensed its CRISPR-Cas9 patent portfolio to research animal and cell model developer GenOway.

Financial terms of the deal were not disclosed.

"This license from ERS will broaden our CRISPR IP portfolio, and widen our rodent models offering," GenOway CEO Alexandre Fraichard said in a statement. "This will ultimately enable us to pursue our mission of providing the scientific community with scientifically highly relevant preclinical models paired with guaranteed freedom to operate, in particular for commercial applications."

Dublin-based ERS was founded to provide access to CRISPR-Cas9 intellectual property held by Emmanuelle Charpentier. The IP is shared between her, Jennifer Doudna and the University of California, and the University of Vienna. The IP is separate from genome editing patents held by the Broad Institute.

Last month, ERS granted a nonexclusive license to the IP to GenScript. Also, in early 2020, Lyon, France-based GenOway extended its nonexclusive license to CRISPR-Cas9 IP held by Merck for applications involving rodent cells or animals.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.